Healthcare provider profile · identity verified

Arnaldo Sanchez, D.O.

Internal Medicine · MIAMI, FL · NPI 1639473515

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	875	260
Losartan Potassium	Losartan Potassium	663	161
Gabapentin	Gabapentin	521	119
Sildenafil Citrate	Sildenafil Citrate	521	101
Lisinopril	Lisinopril	495	126
Rosuvastatin Calcium	Rosuvastatin Calcium	487	141
Metformin Hcl	Metformin Hcl	405	121
Amlodipine Besylate	Amlodipine Besylate	402	123
Omeprazole	Omeprazole	395	137
Levothyroxine Sodium	Levothyroxine Sodium	392	122
Warfarin Sodium	Warfarin Sodium	277	suppressed
Metoprolol Succinate	Metoprolol Succinate	259	88
Xarelto	Rivaroxaban	243	39
Hydrochlorothiazide	Hydrochlorothiazide	236	67
Fluticasone Propionate	Fluticasone Propionate	231	84
Tamsulosin Hcl	Tamsulosin Hcl	230	85
Famotidine	Famotidine	222	72
Metoprolol Tartrate	Metoprolol Tartrate	211	53
Folic Acid	Folic Acid	209	76
Simvastatin	Simvastatin	197	56
Alendronate Sodium	Alendronate Sodium	187	78
Pravastatin Sodium	Pravastatin Sodium	178	44
Eliquis	Apixaban	170	29
Albuterol Sulfate Hfa	Albuterol Sulfate	159	35
Furosemide	Furosemide	158	55
Pantoprazole Sodium	Pantoprazole Sodium	141	55
Vitamin D2	Ergocalciferol (Vitamin D2)	139	62
Temazepam	Temazepam	134	17
Finasteride	Finasteride	124	42
Alprazolam	Alprazolam	122	29
Carvedilol	Carvedilol	111	34
Clopidogrel	Clopidogrel Bisulfate	110	42
Glipizide Er	Glipizide	110	30
Glipizide	Glipizide	106	32
Metformin Hcl Er	Metformin Hcl	106	33
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	96	42
Comfort Ez Pen Needle	Pen Needle, Diabetic	93	28
Buspirone Hcl	Buspirone Hcl	92	36
Nifedipine Er	Nifedipine	89	24
Atenolol	Atenolol	88	25
Montelukast Sodium	Montelukast Sodium	86	33
Lactulose	Lactulose	82	31
Donepezil Hcl	Donepezil Hcl	79	23
Trazodone Hcl	Trazodone Hcl	78	32
Ammonium Lactate	Ammonium Lactate	76	33
Lovastatin	Lovastatin	76	24
Quetiapine Fumarate	Quetiapine Fumarate	70	23
Triamcinolone Acetonide	Triamcinolone Acetonide	70	20
Ibuprofen	Ibuprofen	68	29
Diclofenac Sodium	Diclofenac Sodium	65	37
Sertraline Hcl	Sertraline Hcl	65	21
Clonidine Hcl	Clonidine Hcl	59	15
Shingrix	Varicella-Zoster Ge/As01b/Pf	59	37
Memantine Hcl	Memantine Hcl	58	17
Mirtazapine	Mirtazapine	57	24
Hydrocortisone	Hydrocortisone	56	23
Mupirocin	Mupirocin	55	28
Potassium Chloride	Potassium Chloride	55	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	54	13
Alogliptin	Alogliptin Benzoate	53	14
Irbesartan	Irbesartan	53	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	53	suppressed
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	52	52
Naproxen	Naproxen	52	27
Fenofibrate	Fenofibrate Nanocrystallized	51	15
Allopurinol	Allopurinol	50	16
Doxazosin Mesylate	Doxazosin Mesylate	49	13
Hydralazine Hcl	Hydralazine Hcl	48	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	46	13
Pentoxifylline	Pentoxifylline	45	suppressed
Benzonatate	Benzonatate	44	20
Fenofibrate	Fenofibrate	44	14
Nyamyc	Nystatin	44	16
Pioglitazone Hcl	Pioglitazone Hcl	44	11
Escitalopram Oxalate	Escitalopram Oxalate	42	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	11
Dutasteride	Dutasteride	41	14
Amiodarone Hcl	Amiodarone Hcl	39	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	39	36
Acyclovir	Acyclovir	38	suppressed
Enalapril Maleate	Enalapril Maleate	37	suppressed
Spironolactone	Spironolactone	36	14
Chlorhexidine Gluconate	Chlorhexidine Gluconate	34	12
Dapagliflozin	Dapagliflozin Propanediol	34	13
Pradaxa	Dabigatran Etexilate Mesylate	34	suppressed
Methenamine Hippurate	Methenamine Hippurate	33	suppressed
Ketoconazole	Ketoconazole	32	12
Solifenacin Succinate	Solifenacin Succinate	31	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Tizanidine Hcl	Tizanidine Hcl	29	suppressed
Celecoxib	Celecoxib	28	13
Clonazepam	Clonazepam	28	11
Duloxetine Hcl	Duloxetine Hcl	28	suppressed
Insulin Aspart Flexpen	Insulin Aspart	28	suppressed
Lorazepam	Lorazepam	28	suppressed
Myrbetriq	Mirabegron	28	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Azelastine Hcl	Azelastine Hcl	26	suppressed
Glimepiride	Glimepiride	26	suppressed
Mometasone Furoate	Mometasone Furoate	25	13
Bumetanide	Bumetanide	24	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	suppressed
Baclofen	Baclofen	23	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	23	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Ciclopirox	Ciclopirox	23	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	22	12
Valsartan	Valsartan	22	suppressed
Primidone	Primidone	21	suppressed
Carbamazepine	Carbamazepine	20	suppressed
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	20	suppressed
Ciclopirox	Ciclopirox Olamine	20	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	20	suppressed
Entresto	Sacubitril/Valsartan	20	suppressed
Levoxyl	Levothyroxine Sodium	20	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	19	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	18	18
Candesartan Cilexetil	Candesartan Cilexetil	18	suppressed
Latanoprost	Latanoprost	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Prednisone	Prednisone	18	suppressed
Glyxambi	Empagliflozin/Linagliptin	17	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	16	suppressed
Verapamil Hcl	Verapamil Hcl	16	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Divalproex Sodium Er	Divalproex Sodium	14	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	14	12
Metoclopramide Hcl	Metoclopramide Hcl	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Repaglinide	Repaglinide	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	13	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Comfort Ez Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	13	suppressed
Digoxin	Digoxin	13	suppressed
Cilostazol	Cilostazol	12	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	12	suppressed
Galantamine Er	Galantamine Hbr	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Synjardy	Empagliflozin/Metformin Hcl	12	suppressed
Dapagliflozin-Metformin Er	Dapaglifloz Propaned/Metformin	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Nystatin	Nystatin	11	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error